iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
AKTIENPREIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionBelpointe Asset Management LLC
Latest Disclosed Ownership10,438 shares
Latest Disclosed Value $ 1,762,510
Belpointe Asset Management LLC reports 21.67% decrease in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On April 28, 2026 - Belpointe Asset Management LLC filed a 13F-HR form disclosing ownership of 10,438 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $1,762,510 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 27, 2026 disclosing 13,326 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of -21.67% during the quarter. The current value of the position is $1,367,900 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-28 2026-03-31 13F ISHARES TR ETF 464287556 10,438 -2,888 -21.67 1,763 -21.65 0.0643
2026-01-27 2025-12-31 13F ISHARES TR ETF 464287556 13,326 537 4.20 2,249 21.83 0.0812
2025-11-03 2025-09-30 13F ISHARES TR ETF 464287556 12,789 5,825 83.64 1,846 109.53 0.0705
2025-07-22 2025-06-30 13F ISHARES TR ETF 464287556 6,964 -166 -2.33 881 -3.29 0.0367
2025-05-20 2025-03-31 13F ISHARES TR ETF 464287556 7,130 -440 -5.81 912 -18.73 0.0475
2025-02-13 2024-12-31 13F ISHARES TR ETF 464287556 7,570 21 0.28 1,122 2.00 0.0676
2024-11-13 2024-09-30 13F ISHARES TR ETF 464287556 7,549 3,678 95.01 1,099 106.97 0.0659
2024-08-02 2024-06-30 13F ISHARES TR ETF 464287556 3,871 -126 -3.15 531 -3.10 0.0371
2024-05-08 2024-03-31 13F ISHARES TR ETF 464287556 3,997 -248 -5.84 549 -4.86 0.0411
2024-02-13 2023-12-31 13F ISHARES TR ETF 464287556 4,245 -343 -7.48 577 2.67 0.0507
2023-11-15 2023-09-30 13F ISHARES TR ETF 464287556 4,588 108 2.41 561 -1.23 0.0581
2023-08-15 2023-06-30 13F ISHARES TR ETF 464287556 4,480 -12,373 -73.42 569 -73.90 0.0602
2023-05-15 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 16,853 -12,336 -42.26 2,177 -43.22 0.1176
2023-02-08 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 29,189 -5,612 -16.13 3,832 -5.85 0.2316
2022-11-14 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 34,801 16,121 86.30 4,070 85.34 0.2751
2022-08-02 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 18,680 1,843 10.95 2,196 0.18 0.1472
2022-04-28 2022-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 16,837 -4,984 -22.84 2,192 -34.19 0.1328
2022-02-15 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 21,821 1,469 7.22 3,331 1.22 0.2076
2021-11-15 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 20,352 12,375 155.13 3,291 152.18 0.2244
2021-08-09 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 7,977 421 5.57 1,305 14.67 0.0939
2021-05-14 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 7,556 -1,291 -14.59 1,138 -15.07 0.0974
2021-02-16 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 8,847 1,805 25.63 1,340 40.61 0.1203
2020-11-13 2020-09-30 13F/A-1 ISHARES TR NASDAQ BIOTECH 464287556 7,042 -834 -10.59 953 -11.51 0.1061
2020-11-13 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 7,010 755
2020-07-20 2020-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 7,876 866 12.35 1,077 42.65 0.1394
2020-07-20 2020-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 7,010 -853 -10.85 755 -20.36 0.1322
2020-02-18 2019-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 7,863 685 9.54 948 32.77 0.1203
2020-01-16 2019-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 7,178 9 0.13 714 -8.70 0.1155
2019-11-22 2019-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 7,169 7,169 782 0.1538
2019-06-10 2019-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 0 -6,666 -100.00 0 -100.00
2019-03-06 2018-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 6,666 -1,456 -17.93 643 -35.05 0.1630
2018-11-23 2018-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 8,122 2,192 36.96 990 52.07 0.1566
2018-08-06 2018-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 5,930 -28,779 -82.92 651 -82.43 0.1819
2018-08-06 2018-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 34,709 26,299 312.71 3,705 312.58 1.0800
2018-02-14 2017-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 8,410 -2,976 -26.14 898 -76.36 0.1967
2017-11-16 2017-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 11,386 11,386 3,798 0.8885
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.